… Mature DCs present tumor antigen through type II histocompatibility antigen (MHCII),
resisting the immune escape of … tumor鄄derived cells in patients with stage IV renal cell …

… , or discontinuation due to financial issues. The first dosage of … metastatic colorectal cancer
that underwent multiple previous chemotherapy treatments who experienced recent treatment …

… At present, only one article 3 has reported the inhibition of Imatinib on a NPC cell line, …
Expression of HER2 and C鄄KIT in nasopharyngeal carcinoma: implications for a new therapeutic …

… Sebaceous carcinoma is apparently less sensitive, but still prompts the consideration of Muir…
mutations in internal tumors and sebaceous lesions, our case could present a sporadic type. …

… texts and current usage in disease and therapy relating to zSpleen. This present model will
be … digestive, immunologic aspects on one hand and neuro-endocrinal aspects on the other …

… In recent years, studies have found that exosomes can participate in the development of
cardiovascular diseases and play an important role in diagnosis and treatment of cardiovascular …

… of metastatic renal cell carcinoma should be revalued. Based on the results and related
considerations of above two studies, we reviewed recent … in metastatic renal cell carcinoma. …

… of extremity bone metastasis is a key consideration in averting … Current guidelines suggest
that surgical treatment for bone … of our sample, renal cell carcinoma metastasis is reputed to …

… of extremity bone metastasis is a key consideration in averting … Current guidelines suggest
that surgical treatment for bone … of our sample, renal cell carcinoma metastasis is reputed to …

… is based on the molecular biological aspects of a tumor. … : advanced renal carcinoma, targeted
treatment, current status … Is there still a role for sorafenib in metastatic renal cell carcinoma…